 | Up a level |
Hennes, Eva-Maria; Baumann, Matthias; Schanda, Kathrin; Anlar, Banu; Bajer-Kornek, Barbara; Blaschek, Astrid; Brantner-Inthaler, Sigrid; Diepold, Katharina; Eisenkölbl, Astrid; Gotwald, Thaddäus; Kuchukhidze, Georgi; Gruber-Sedlmayr, Ursula; Häusler, Martin; Höftberger, Romana; Karenfort, Michael; Klein, Andrea; Koch, Johannes; Kraus, Verena; Lechner, Christian; Leiz, Steffen; ... (2017). Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology, 89(9), pp. 900-908. Lippincott Williams & Wilkins 10.1212/WNL.0000000000004312
Sadovnick, A Dessa; Traboulsee, Anthony L; Bernales, Cecily Q; Ross, Jay P; Forwell, Amanda L; Yee, Irene M; Guillot-Noel, Lena; Fontaine, Bertrand; Cournu-Rebeix, Isabelle; Alcina, Antonio; Fedetz, Maria; Izquierdo, Guillermo; Matesanz, Fuencisla; Hilven, Kelly; Dubois, Bénédicte; Goris, An; Astobiza, Ianire; Alloza, Iraide; Antigüedad, Alfredo; Vandenbroeck, Koen; ... (2016). Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients. G3 Genes Genomes Genetics, 6(7), pp. 2073-2079. Genetics Society of America 10.1534/g3.116.030841
Lassmann, Hans; Reindl, Markus; Rauschka, Helmut; Berger, Johannes; Aboul‐Enein, Fahmy; Berger, Thomas; Zurbriggen, Andreas; Lutterotti, Andreas; Brück, Wolfgang; Weber, Jörg R.; Ullrich, Robert; Schmidbauer, Manfred; Jellinger, Kurt; Vandevelde, Marc (2003). A new paraclinical CSF marker for hypoxia‐like tissue damage in multiple sclerosis lesions. Brain, 126(6), pp. 1347-1357. Oxford University Press 10.1093/brain/awg127
